Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
Peptide systems that address multiple disease dimensionssuch as metabolic control, functional capacity, and psychological well-beingmay be well positioned to meet these criteria, provided that clinical trials are designed to capture these outcomes
The complete cagrilintide dosing protocol Cagrilintide follows a slow titration schedule
Some online telehealth services offer consultations and prescriptions which can be convenient for those who prefer remote healthcare services
However, this same property necessitates careful dosing considerations, as excessive copper-catalyzed oxidation can generate hydroxyl radicals through Fenton chemistry
doi: 10.1038/nm.3145.[PMC free article] [PubMed] [CrossRef] Kolker S, Christensen E, Leonard JV, et al